Trump announces trade deal with EU following months of negotiations
In a remarkable display of market confidence, shares of NCS Multistage Holdings , Inc. (NASDAQ:NCSM) have surged to a 52-week high, reaching a price level of $38.2. According to InvestingPro data, the company maintains a "GREAT" financial health score of 3.11, with a market capitalization of $95 million. This peak represents a significant milestone for the company, reflecting a robust period of growth and investor optimism. Over the past year, NCSM has witnessed an impressive 125.3% return, trading at a modest P/E ratio of 13.9. The company’s revenue grew by 14.1% in the last twelve months, with its next earnings report expected on April 30, 2025. Investors are closely monitoring NCSM’s trajectory as it continues to navigate the market with promising results. Discover more insights and 8 additional ProTips for NCSM with an InvestingPro subscription.
In other recent news, NCS Multistage Holdings Inc. reported a significant earnings beat for the fourth quarter of 2024, with earnings per share reaching $1.32, surpassing the forecast of $0.73. The company also saw a 20% increase in quarterly revenue, totaling $45 million, which exceeded expectations of $40.6 million. This strong performance was attributed to international expansion, which doubled the company’s international revenue share from 5% to 10%. Analysts noted that improved gross margins and operational efficiencies contributed to this earnings surprise. Additionally, NCS Multistage has been exploring mergers and acquisitions, as discussed during their earnings call, highlighting ongoing strategic initiatives for growth. The company has projected 2025 revenue between $165 million and $175 million, with adjusted EBITDA expected to range from $20 million to $23 million. Analyst firms have not reported any recent upgrades or downgrades for NCS Multistage. The company’s CEO, Ryan Hummer, emphasized the resilience and operational strength demonstrated in a challenging market environment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.